Pancreatic Cancer Research

ResearcherPennsylvania State UniversityActive in the last 2 years

Junxuan Lü

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2354-7186; OpenAlex author ID A5010296048. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. Library Screening and Preliminary Characterization of Synthetic Cannabinoids Against Prostate and Pancreatic Cancer Cell Lines. Co-author DOI 10.1089/can.2022.0270↗
  2. Novel Seleno-Aspirinyl Compound AS-10 Induces Apoptosis, G1 Arrest of Pancreatic Ductal Adenocarcinoma Cells, Inhibits Their NF-κB Signaling, and Synergizes wi… Co-author DOI 10.3390/ijms22094966↗
  3. Methylseleninic acid suppresses pancreatic cancer growth involving multiple pathways. Last author DOI 10.1080/01635581.2014.868911↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Deepkamal N. Karelia · 2 shared papers, 2021–2024 · strength 0.39
  2. Cheng Jiang · 1 shared paper, 2024 · strength 0.24
  3. Arun Kumar Sharma · 1 shared paper, 2021 · strength 0.15
  4. Manoj Kumar Pandey · 1 shared paper, 2021 · strength 0.15
  5. Lei Wang · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.